Campa, Carlo C.
Silva, Rangel L.
Margaria, Jean P.
Pirali, Tracey http://orcid.org/0000-0003-3936-4787
Mattos, Matheus S.
Kraemer, Lucas R.
Reis, Diego C.
Grosa, Giorgio
Copperi, Francesca
Dalmarco, Eduardo M.
Lima-JĂșnior, Roberto C. P.
Aprile, Silvio
Sala, Valentina http://orcid.org/0000-0002-2283-2807
Dal Bello, Federica http://orcid.org/0000-0003-0726-3025
Prado, Douglas Silva
Alves-Filho, Jose Carlos http://orcid.org/0000-0002-9918-8714
Medana, Claudio
Cassali, Geovanni D.
Tron, Gian Cesare
Teixeira, Mauro M.
Ciraolo, Elisa http://orcid.org/0000-0002-5601-1695
Russo, Remo C.
Hirsch, Emilio http://orcid.org/0000-0002-9073-6024
Article History
Received: 16 April 2018
Accepted: 14 November 2018
First Online: 12 December 2018
Competing interests
: E.H. and G.C.T. are co-founders of Kither Biotech, a company involved in the development of PI3K inhibitors. The other authors declare no competing interests.